DEF 14A

Company

Jazz Pharmaceuticals plc

Filed

June 11, 2021

Period of Report

July 29, 2021

Accession Number

0001193125-21-188926

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →